Chronic myeloid leukemia (CML) is a hematological tumor driven by the BCR-ABL1 fusion protein, which constitutively activates tyrosine kinases. The gene discussed is BCR; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.